On behalf of the Canadian Arthritis Patient Alliance (CAPA), we welcomed the opportunity to provide feedback on the draft guidance for biosimilar biologic drugs. Ensuring that patient perspectives are included in the development of policies is essential to improving...
English 
Français du Canada